Research study request from IVF Hammersmith: The use of the hormone kisspeptin in IVF treatment

The use of the hormone kisspeptin in IVF treatment

We are currently conducting a trial of a hormone called kisspeptin in IVF treatment. The study will investigate whether kisspeptin can stimulate egg maturation in IVF therapy. Research cycles will be fully funded and participation does not affect eligibility for future NHS care.

In order to take part you need to have:

· Age 18–34 years

· BMI 18-29 kg/m2

· Normal menstrual cycles ranging from 24-35 days in length

· No more than one previous IVF treatment cycle

· Both ovaries intact

· Normal Blood tests (E.g. Follicular phase serum FSH concentration (=12iu/l), Serum AMH (>10pmol/L))

Please email kisspeptin.ivf@imperial.ac.uk if you would like more information

Thank you

Professor Waljit Dhillo, Dr Geoff Trew, Dr Anna Carby

oldestnewest

You may also like...